TKNO (TKNO) Stock Price & Analysis
TKNO (TKNO) fell 0.58% to USD 6.88 as of September 8, 2026 at 20:51 UTC, according to Nexqual real-time market data.
TKNO last closed at USD 6.88; the session ranged USD 6.78–7.07 on volume of 134,752 shares. Market capitalization is —, with a 52-week range of USD 1.91–7.84 (NGM). Source: Nexqual, September 8, 2026 at 20:51 UTC.
Key Statistics (as of September 8, 2026 at 20:51 UTC)
| Price | USD 6.88 |
|---|---|
| Change | ▼ 0.58% (down) |
| Previous Close | USD 6.88 |
| Open | USD 6.88 |
| Day Range | USD 6.78 – 7.07 |
| 52-Week Range | USD 1.91 – 7.84 |
| Volume | 134,752 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TKNO)
Nexqual's technical model rates TKNO "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 20:51 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.89 (neutral) |
| vs SMA50 | Above (USD 6.16) |
| MACD | 0.28 (positive) |
From TKNO's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | USD 3.89 | ▼ 2.02% |
| RLYB | Rallybio Corporation | USD 16.61 | ▼ 1.57% |
| SERA | Sera Prognostics, Inc. | USD 2.01 | ▲ 1.52% |
| IPSC | Century Therapeutics, Inc. | USD 2.07 | ▼ 0.96% |
| XGN | Exagen Inc. | USD 7.3 | ▼ 3.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 20:51 UTC. This page is informational and not investment advice.